Type:Notice
Citation:89 FR 106589
Reading Time:about a minute or two
Curia New York, Inc. has applied to the Drug Enforcement Administration (DEA) to become an importer of controlled substances. The company intends to use these substances in bulk manufacturing to produce other controlled substances for their clients. Public feedback on the application can be submitted electronically until January 29, 2025. The application must align with DEA regulations and does not permit importing finished or unfinished drug products for commercial sale.
Simple Explanation
Curia New York, Inc. wants government permission to bring in special chemicals to make medicines for other companies. People can tell the government what they think about this until January 29, 2025.